We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

47 hedge funds and large institutions have $125M invested in SQZ Biotechnologies Company in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

31% more funds holding

Funds holding: 36 → 47 (+11)

47% less capital invested

Capital invested by funds: $234M → $125M (-$109M)

Holders
47
Holders Change
+11
Holders Change %
+30.56%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
21
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIG
American International Group
New York
+$51.1M
2
LM
Luminus Management
Texas
+$9.55M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.98M
4
6CM
683 Capital Management
New York
+$2.47M
5
Walleye Capital
Walleye Capital
New York
+$1.34M

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$505K
2
CCM
CAAS Capital Management
New York
-$369K
3
N
Nuveen
North Carolina
-$212K
4
EMG
ETF Managers Group
New Jersey
-$63.5K
5
Morgan Stanley
Morgan Stanley
New York
-$35.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$34.4M – – –
AG
2
Artal Group
Luxembourg
$22M +$20 +1 +0%
MC
3
Maverick Capital
Texas
$13.1M +$485K +23,861 +3%
AI
4
Alphabet Inc
California
$11.4M – – –
BM
5
Bridger Management
New York
$9.96M – – –
6CM
6
683 Capital Management
New York
$8.04M +$2.47M +121,802 +26%
LM
7
Luminus Management
Texas
$6.43M +$9.55M +470,007 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$5.06M +$2.98M +146,679 +66%
BlackRock
9
BlackRock
New York
$3.18M +$442K +21,750 +10%
CCM
10
CAAS Capital Management
New York
$1.8M -$369K -18,151 -12%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.22M +$295K +14,522 +19%
State Street
12
State Street
Massachusetts
$929K +$256K +12,613 +23%
Northern Trust
13
Northern Trust
Illinois
$875K +$189K +9,304 +17%
Tudor Investment Corp
14
Tudor Investment Corp
Connecticut
$711K +$1.06M +51,998 New
WP
15
Woodline Partners
California
$707K +$1.05M +51,662 New
Charles Schwab
16
Charles Schwab
California
$624K +$419K +20,612 +82%
Two Sigma Investments
17
Two Sigma Investments
New York
$591K +$877K +43,193 New
SG Americas Securities
18
SG Americas Securities
New York
$553K +$516K +25,414 +169%
Millennium Management
19
Millennium Management
New York
$425K +$630K +31,033 New
Bank of America
20
Bank of America
North Carolina
$391K +$520K +25,613 +870%
Goldman Sachs
21
Goldman Sachs
New York
$348K +$106K +5,197 +26%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$329K +$488K +24,030 New
Squarepoint
23
Squarepoint
New York
$233K +$346K +17,038 New
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$227K +$337K +16,593 New
RAM
25
Redmond Asset Management
Virginia
$224K +$334K +16,436 New
1
2

SQZ Hedge Fund Activity: Q1 2021 in Review

47 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q1 2021, worth a combined $125M — down 47% from $234M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new SQZ positions and 2 closed out — a net gain of 11 holders — while 21 added to existing stakes and 7 trimmed.

The largest buyer was American International Group, adding an estimated $51.1M. The largest seller was HRT Financial, exiting entirely with an estimated $505K sold.

  • 47 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q1 2021, up from 36 in Q4 2020.
  • Funds reported $125M of SQZ Biotechnologies Company stock for Q1 2021, down 47% quarter-over-quarter.
  • 13 funds opened new SQZ Biotechnologies Company positions in Q1 2021 and 2 closed out, a net change of +11 holders.
  • The largest SQZ Biotechnologies Company buyer in Q1 2021 was American International Group, an estimated $51.1M added.
  • The largest SQZ Biotechnologies Company seller in Q1 2021 was HRT Financial, an estimated $505K sold.

Based on aggregated 13F filings for Q1 2021.